Lincoln Pharma launches ear spray for tinnitus cure

Virendra Pandit Ahmedabad | Updated on January 21, 2013 Published on January 21, 2013

Lincoln Pharmaceuticals Ltd (LPL) on Monday said it has introduced in the country an ear spray to cure the ‘ringing problem’.

The Ahmedabad-based company had entered into an agreement with Phafag AG, Switzerland, for its Caroverine molecule for the treatment of tinnitus, commonly known as “ringing in the ear”, a condition where the inner hair cells get damaged causing continuous depression, anxiety and insomnia in patients. Millions around the world suffer from tinnitus.

LPL became the first company in India to introduce a cure for tinnitus with the launch of the Tinnex injection and capsule. Now LPL has introduced the Tinnex ear spray.

“A study reveals that 10-15 per cent of Indians suffer from tinnitus. It is a condition in which people hear abnormal sounds, noise, ringing in their ear without the objective sound source near them. It’s a disease that is increasing among the youth of the country too,” Mahendra G. Patel, Managing Director said, quoting Dr Klaus Ehrenberger, former head of the Department of Otolarhingology, Medical University, Vienna, Austria.

Dr Ehrenberger, on a visit to India to present his research papers on the treatment of ENT, said “incidence of tinnitus in Indians in the age group of 70-80 years is 40 per cent.”

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on January 21, 2013
This article is closed for comments.
Please Email the Editor